News and views
Our magazine
Insights gives you all the news from the labs, hot topics, health tips and personal stories. Available as a free monthly email or twice-yearly magazine.
Sign up for more news and views
Campaigning
We want men with prostate cancer to get better diagnosis, better treatment and better support. But we can’t do it alone: we need your help.
Join the fightA year of leaps: 2019 was historic for prostate cancer research
The last year saw the announcement of the world’s first precision medicine for prostate cancer and huge progress towards the development of a home urine test. Just some of the things that made 2019 one of the most innovative years in prostate cancer research history.
Brookside legend Dean Sullivan reveals he was treated for prostate cancer
Ahead of hosting our Carol concert in Liverpool this December, legendary British actor Dean Sullivan, known for playing lovable rogue Jimmy Corkhill in Brookside, speaks about his treatment and diagnosis.
"A picture of genuine kindness": nurse Amelia Barber wins People's Choice Award
Nurse Amelia Barber, from Guy’s Hospital in London wins the People’s Choice Award winner for her outstanding dedication to supporting men with prostate cancer.
Bill Turnbull: on chemo and the making of his documentary, Staying Alive
Ahead of tonight's documentary we spoke to our ambassador Bill Turnbull about diagnosis, chemotherapy and the Turnbull/Fry effect.
Separating fact from fiction: Revealing the truth behind common prostate cancer myths.
There are so many myths out there about prostate cancer and lots of misunderstanding about who is at risk, how to be tested and when to have treatment. Our Specialist Nurse Meg lays the facts on the line.
Enzalutamide has similar benefit to chemo when taken with hormone therapy
For the third time in four years, researchers have found a new treatment option to combine with hormone therapy and improve life expectancy for men with advanced prostate cancer.
New guidelines prompt doctors to offer active surveillance for low risk cancers
We publish new best practice guidelines on active surveillance, as NICE advise it should be offered to men with low risk localised prostate cancer.
Focal therapy is put to the test in new trial
Focal therapy causes fewer side effects when treating localised prostate cancer, so we’re funding a new trial to see if it’s possible to compare it against surgery and radiotherapy.
The Manual: Coping with the emotional fallout from prostate cancer
Health psychologist Dr Emily Robson answers some of your questions and concerns about coping with the emotional fallout from prostate cancer.
LAPCD study reveals lack of support for sexual side effects of prostate cancer treatment
Over 80 per cent of men living between 18 and 42 months after a diagnosis of prostate cancer struggle with poor sexual function, yet fewer than half of these men are offered any support to cope with it.